One Bio Stock

One Bio Equity

The The Equity of One Bio (ONBI) as of Jul 21, 2026 is 42.09 M USD.

Equity

42.09 MUSD

Last updated:

In 2026, One Bio's equity was 42.09 M USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

One Bio Stock analysis

What does One Bio do? One Bio Corp is a US-based company specializing in biotechnological research, development, and production of biological and similar products. The company is headquartered in Miami, Florida and was founded in 1978. The history of One Bio Corp began with the development of enzymatic cleaning agents for the carpet industry in the late 1970s. Over the years, the company has become a key player in the field of biotechnology and the life sciences through acquisitions, mergers, and partnerships. Through its research and development efforts, One Bio Corp has been able to develop a wide range of products and services for various industries such as pharmaceuticals, cosmetics, food, animal feed, agriculture, and environmental technology. One Bio Corp offers a wide range of products for various applications. These include DNA test kits for pets and horses, dietary supplements for humans and animals, as well as pesticides and fungicides for agriculture. Additionally, One Bio Corp also provides diagnostic and testing services for infectious diseases and other health-related tests. One Bio Corp has several divisions focusing on different aspects of biotechnology and biological research. This includes the Life Sciences division, which focuses on the development of dietary supplements, diagnostic tests, and cosmetic products. The Agricultural Solutions division offers pesticides, fungicides, and other products for agriculture. The Veterinary Diagnostics division provides DNA test kits for pets and horses. Lastly, the Environmental Solutions division specializes in the development of products and services to improve environmental quality. One Bio Corp's business model is focused on long-term growth and success. The company concentrates on developing products and services that meet the needs of customers and end consumers. One Bio Corp pursues a strong marketing and distribution strategy to successfully market and promote its products and services. Additionally, the company collaborates closely with partners and research institutions to develop innovative technologies and products. Overall, One Bio Corp is an innovative biotechnological company that focuses on developing products and services tailored to the needs of customers and end consumers. The company follows a clear business strategy and relies on innovative research and development to achieve long-term growth and success. One Bio is one of the most popular companies on Eulerpool.

Equity Details

Analyzing One Bio's Equity

One Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding One Bio's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating One Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

One Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in One Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about One Bio stock

The Equity of One Bio is 42.09 M USD in 2026.

Access this data via the Eulerpool API

Balance Sheet — One Bio

All Key Metrics — One Bio